Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

Featured Host
×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11610477
archived
Play

In this session recorded at the 7th annual Chief Medical Officer Summit, Dr Steve Kanes, Chief Medical Officer, Sage Therapeutics, discusses how a company considered as an "up and comer" in the Cambridge biotech sector navigated the development and approval of the first treatment specifically designed for postpartum depression.

Learn more at theconferenceforum.org

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled